Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Karen Klahr Miller, M.D.

Co-Author

Back to Details
This page shows the publications co-authored by Karen Miller and Madhusmita Misra.
Karen Miller
Connection Strength
7.107
Madhusmita Misra
  1. Sequential Therapy With Recombinant Human IGF-1 Followed by Risedronate Increases Spine Bone Mineral Density in Women With Anorexia Nervosa: A Randomized, Placebo-Controlled Trial. J Bone Miner Res. 2021 11; 36(11):2116-2126.
    View in: PubMed
    Score: 0.239
  2. Effect of Transdermal Estradiol and Insulin-like Growth Factor-1 on Bone Endpoints of Young Women With Anorexia Nervosa. J Clin Endocrinol Metab. 2021 06 16; 106(7):2021-2035.
    View in: PubMed
    Score: 0.236
  3. A Randomized Placebo-Controlled Trial of Low-Dose Testosterone Therapy in Women With Anorexia Nervosa. J Clin Endocrinol Metab. 2019 10 01; 104(10):4347-4355.
    View in: PubMed
    Score: 0.209
  4. Differences in Trabecular Plate and Rod Structure in Premenopausal Women Across the Weight Spectrum. J Clin Endocrinol Metab. 2019 10 01; 104(10):4501-4510.
    View in: PubMed
    Score: 0.209
  5. Bone mineral density and estimated hip strength in men with anorexia nervosa, atypical anorexia nervosa and avoidant/restrictive food intake disorder. Clin Endocrinol (Oxf). 2019 06; 90(6):789-797.
    View in: PubMed
    Score: 0.202
  6. Suboptimal bone microarchitecure in adolescent girls with obesity compared to normal-weight controls and girls with anorexia nervosa. Bone. 2019 05; 122:246-253.
    View in: PubMed
    Score: 0.201
  7. Erratum to: Impact of low-weight severity and menstrual status on bone in adolescent girls with anorexia nervosa. Int J Eat Disord. 2017 10; 50(10):1239.
    View in: PubMed
    Score: 0.180
  8. Impact of low-weight severity and menstrual status on bone in adolescent girls with anorexia nervosa. Int J Eat Disord. 2017 Apr; 50(4):359-369.
    View in: PubMed
    Score: 0.174
  9. Vertebral Volumetric Bone Density and Strength Are Impaired in Women With Low-Weight and Atypical Anorexia Nervosa. J Clin Endocrinol Metab. 2017 01 01; 102(1):57-68.
    View in: PubMed
    Score: 0.173
  10. Bone density, body composition, and psychopathology of anorexia nervosa spectrum disorders in DSM-IV vs DSM-5. Int J Eat Disord. 2017 Apr; 50(4):343-351.
    View in: PubMed
    Score: 0.169
  11. Vertebral Strength and Estimated Fracture Risk Across the BMI Spectrum in Women. J Bone Miner Res. 2016 Feb; 31(2):281-8.
    View in: PubMed
    Score: 0.158
  12. Appetite regulatory hormones in women with anorexia nervosa: binge-eating/purging versus restricting type. J Clin Psychiatry. 2015 Jan; 76(1):19-24.
    View in: PubMed
    Score: 0.151
  13. Impact of physiologic estrogen replacement on anxiety symptoms, body shape perception, and eating attitudes in adolescent girls with anorexia nervosa: data from a randomized controlled trial. J Clin Psychiatry. 2013 Aug; 74(8):e765-71.
    View in: PubMed
    Score: 0.136
  14. Hip structural analysis in adolescent boys with anorexia nervosa and controls. J Clin Endocrinol Metab. 2013 Jul; 98(7):2952-8.
    View in: PubMed
    Score: 0.134
  15. Sclerostin levels and bone turnover markers in adolescents with anorexia nervosa and healthy adolescent girls. Bone. 2012 Sep; 51(3):474-9.
    View in: PubMed
    Score: 0.126
  16. Estradiol levels predict bone mineral density in male collegiate athletes: a pilot study. Clin Endocrinol (Oxf). 2012 Mar; 76(3):339-45.
    View in: PubMed
    Score: 0.124
  17. Physiologic estrogen replacement increases bone density in adolescent girls with anorexia nervosa. J Bone Miner Res. 2011 Oct; 26(10):2430-8.
    View in: PubMed
    Score: 0.120
  18. Effects of risedronate and low-dose transdermal testosterone on bone mineral density in women with anorexia nervosa: a randomized, placebo-controlled study. J Clin Endocrinol Metab. 2011 Jul; 96(7):2081-8.
    View in: PubMed
    Score: 0.117
  19. Use of SSRIs may Impact Bone Density in Adolescent and Young Women with Anorexia Nervosa. CNS Spectr. 2010 Sep; 15(9):579-586.
    View in: PubMed
    Score: 0.112
  20. Comparison of DXA and CT in the assessment of body composition in premenopausal women with obesity and anorexia nervosa. Obesity (Silver Spring). 2010 Nov; 18(11):2227-33.
    View in: PubMed
    Score: 0.107
  21. Visceral fat is a negative predictor of bone density measures in obese adolescent girls. J Clin Endocrinol Metab. 2010 Mar; 95(3):1247-55.
    View in: PubMed
    Score: 0.107
  22. Reduced amylin levels are associated with low bone mineral density in women with anorexia nervosa. Bone. 2010 Mar; 46(3):796-800.
    View in: PubMed
    Score: 0.106
  23. Effects of rhIGF-1 administration on surrogate markers of bone turnover in adolescents with anorexia nervosa. Bone. 2009 Sep; 45(3):493-8.
    View in: PubMed
    Score: 0.102
  24. Relative growth hormone deficiency and cortisol excess are associated with increased cardiovascular risk markers in obese adolescent girls. J Clin Endocrinol Metab. 2009 Aug; 94(8):2864-71.
    View in: PubMed
    Score: 0.102
  25. Peptide YY in adolescent athletes with amenorrhea, eumenorrheic athletes and non-athletic controls. Bone. 2009 Jul; 45(1):104-9.
    View in: PubMed
    Score: 0.101
  26. Increased carbohydrate induced ghrelin secretion in obese vs. normal-weight adolescent girls. Obesity (Silver Spring). 2009 Sep; 17(9):1689-95.
    View in: PubMed
    Score: 0.101
  27. Adrenal glucocorticoid and androgen precursor dissociation in anorexia nervosa. J Clin Endocrinol Metab. 2009 Apr; 94(4):1367-71.
    View in: PubMed
    Score: 0.100
  28. Percentage extremity fat, but not percentage trunk fat, is lower in adolescent boys with anorexia nervosa than in healthy adolescents. Am J Clin Nutr. 2008 Dec; 88(6):1478-84.
    View in: PubMed
    Score: 0.099
  29. Bone metabolism in adolescent boys with anorexia nervosa. J Clin Endocrinol Metab. 2008 Aug; 93(8):3029-36.
    View in: PubMed
    Score: 0.096
  30. Lower growth hormone and higher cortisol are associated with greater visceral adiposity, intramyocellular lipids, and insulin resistance in overweight girls. Am J Physiol Endocrinol Metab. 2008 Aug; 295(2):E385-92.
    View in: PubMed
    Score: 0.096
  31. Bone metabolism in adolescent athletes with amenorrhea, athletes with eumenorrhea, and control subjects. Pediatrics. 2008 Jun; 121(6):1127-36.
    View in: PubMed
    Score: 0.095
  32. Peptide YY (PYY) levels and bone mineral density (BMD) in women with anorexia nervosa. Bone. 2008 Jul; 43(1):135-139.
    View in: PubMed
    Score: 0.094
  33. Acylated ghrelin and leptin in adolescent athletes with amenorrhea, eumenorrheic athletes and controls: a cross-sectional study. Clin Endocrinol (Oxf). 2008 Oct; 69(4):628-33.
    View in: PubMed
    Score: 0.094
  34. Prognostic indicators of changes in bone density measures in adolescent girls with anorexia nervosa-II. J Clin Endocrinol Metab. 2008 Apr; 93(4):1292-7.
    View in: PubMed
    Score: 0.092
  35. Weight gain and restoration of menses as predictors of bone mineral density change in adolescent girls with anorexia nervosa-1. J Clin Endocrinol Metab. 2008 Apr; 93(4):1231-7.
    View in: PubMed
    Score: 0.092
  36. Growth hormone suppression after an oral glucose load in children. J Clin Endocrinol Metab. 2007 Dec; 92(12):4623-9.
    View in: PubMed
    Score: 0.091
  37. Androgen deficiency: association with increased anxiety and depression symptom severity in anorexia nervosa. J Clin Psychiatry. 2007 Jun; 68(6):959-65.
    View in: PubMed
    Score: 0.089
  38. Relationships between serum adipokines, insulin levels, and bone density in girls with anorexia nervosa. J Clin Endocrinol Metab. 2007 Jun; 92(6):2046-52.
    View in: PubMed
    Score: 0.088
  39. Androgens in women with anorexia nervosa and normal-weight women with hypothalamic amenorrhea. J Clin Endocrinol Metab. 2007 Apr; 92(4):1334-9.
    View in: PubMed
    Score: 0.087
  40. Uncoupling of cardiovascular risk markers in adolescent girls with anorexia nervosa. J Pediatr. 2006 Dec; 149(6):763-769.
    View in: PubMed
    Score: 0.086
  41. Nutrient intake in community-dwelling adolescent girls with anorexia nervosa and in healthy adolescents. Am J Clin Nutr. 2006 Oct; 84(4):698-706.
    View in: PubMed
    Score: 0.085
  42. Determinants of skeletal loss and recovery in anorexia nervosa. J Clin Endocrinol Metab. 2006 Aug; 91(8):2931-7.
    View in: PubMed
    Score: 0.083
  43. Role of cortisol in menstrual recovery in adolescent girls with anorexia nervosa. Pediatr Res. 2006 Apr; 59(4 Pt 1):598-603.
    View in: PubMed
    Score: 0.082
  44. Elevated peptide YY levels in adolescent girls with anorexia nervosa. J Clin Endocrinol Metab. 2006 Mar; 91(3):1027-33.
    View in: PubMed
    Score: 0.080
  45. Ghrelin and bone metabolism in adolescent girls with anorexia nervosa and healthy adolescents. J Clin Endocrinol Metab. 2005 Sep; 90(9):5082-7.
    View in: PubMed
    Score: 0.078
  46. Secretory dynamics of leptin in adolescent girls with anorexia nervosa and healthy adolescents. Am J Physiol Endocrinol Metab. 2005 Sep; 289(3):E373-81.
    View in: PubMed
    Score: 0.077
  47. Secretory dynamics of ghrelin in adolescent girls with anorexia nervosa and healthy adolescents. Am J Physiol Endocrinol Metab. 2005 Aug; 289(2):E347-56.
    View in: PubMed
    Score: 0.076
  48. Hormonal determinants of regional body composition in adolescent girls with anorexia nervosa and controls. J Clin Endocrinol Metab. 2005 May; 90(5):2580-7.
    View in: PubMed
    Score: 0.076
  49. Effects of anorexia nervosa on clinical, hematologic, biochemical, and bone density parameters in community-dwelling adolescent girls. Pediatrics. 2004 Dec; 114(6):1574-83.
    View in: PubMed
    Score: 0.075
  50. Alterations in cortisol secretory dynamics in adolescent girls with anorexia nervosa and effects on bone metabolism. J Clin Endocrinol Metab. 2004 Oct; 89(10):4972-80.
    View in: PubMed
    Score: 0.074
  51. Hormonal and body composition predictors of soluble leptin receptor, leptin, and free leptin index in adolescent girls with anorexia nervosa and controls and relation to insulin sensitivity. J Clin Endocrinol Metab. 2004 Jul; 89(7):3486-95.
    View in: PubMed
    Score: 0.073
  52. Growth hormone and ghrelin responses to an oral glucose load in adolescent girls with anorexia nervosa and controls. J Clin Endocrinol Metab. 2004 Apr; 89(4):1605-12.
    View in: PubMed
    Score: 0.071
  53. Alterations in growth hormone secretory dynamics in adolescent girls with anorexia nervosa and effects on bone metabolism. J Clin Endocrinol Metab. 2003 Dec; 88(12):5615-23.
    View in: PubMed
    Score: 0.070
  54. Serum osteoprotegerin in adolescent girls with anorexia nervosa. J Clin Endocrinol Metab. 2003 Aug; 88(8):3816-22.
    View in: PubMed
    Score: 0.068
  55. Regional body composition in adolescents with anorexia nervosa and changes with weight recovery. Am J Clin Nutr. 2003 Jun; 77(6):1361-7.
    View in: PubMed
    Score: 0.067
  56. Disrupted Oxytocin-Appetite Signaling in Females With Anorexia Nervosa. J Clin Endocrinol Metab. 2019 10 01; 104(10):4931-4940.
    View in: PubMed
    Score: 0.052
  57. Endogenous Oxytocin Levels in Relation to Food Intake, Menstrual Phase, and Age in Females. J Clin Endocrinol Metab. 2019 04 01; 104(4):1348-1356.
    View in: PubMed
    Score: 0.051
  58. Impaired bone strength estimates at the distal tibia and its determinants in adolescents with anorexia nervosa. Bone. 2018 Jan; 106:61-68.
    View in: PubMed
    Score: 0.045
  59. Leptin secretory dynamics and associated disordered eating psychopathology across the weight spectrum. Eur J Endocrinol. 2016 Apr; 174(4):503-12.
    View in: PubMed
    Score: 0.041
  60. Teriparatide increases bone formation and bone mineral density in adult women with anorexia nervosa. J Clin Endocrinol Metab. 2014 Apr; 99(4):1322-9.
    View in: PubMed
    Score: 0.035
  61. Fracture risk and areal bone mineral density in adolescent females with anorexia nervosa. Int J Eat Disord. 2014 Jul; 47(5):458-66.
    View in: PubMed
    Score: 0.035
  62. Inhibition of Pref-1 (preadipocyte factor 1) by oestradiol in adolescent girls with anorexia nervosa is associated with improvement in lumbar bone mineral density. Clin Endocrinol (Oxf). 2013 Sep; 79(3):326-32.
    View in: PubMed
    Score: 0.034
  63. Adolescent girls with anorexia nervosa have impaired cortical and trabecular microarchitecture and lower estimated bone strength at the distal radius. J Clin Endocrinol Metab. 2013 May; 98(5):1923-9.
    View in: PubMed
    Score: 0.033
  64. Plasma sodium level is associated with bone loss severity in women with anorexia nervosa: a cross-sectional study. J Clin Psychiatry. 2012 Nov; 73(11):e1379-83.
    View in: PubMed
    Score: 0.032
  65. Psychotropic medication use in anorexia nervosa between 1997 and 2009. Int J Eat Disord. 2012 Dec; 45(8):970-6.
    View in: PubMed
    Score: 0.032
  66. Leptin levels are associated with decreased depressive symptoms in women across the weight spectrum, independent of body fat. Clin Endocrinol (Oxf). 2012 Apr; 76(4):520-5.
    View in: PubMed
    Score: 0.031
  67. Decreased nocturnal oxytocin levels in anorexia nervosa are associated with low bone mineral density and fat mass. J Clin Psychiatry. 2011 Nov; 72(11):1546-51.
    View in: PubMed
    Score: 0.030
  68. Appetite-regulating hormones cortisol and peptide YY are associated with disordered eating psychopathology, independent of body mass index. Eur J Endocrinol. 2011 Feb; 164(2):253-61.
    View in: PubMed
    Score: 0.028
  69. Women with anorexia nervosa: finite element and trabecular structure analysis by using flat-panel volume CT. Radiology. 2010 Oct; 257(1):167-74.
    View in: PubMed
    Score: 0.028
  70. Effects of recombinant human growth hormone in anorexia nervosa: a randomized, placebo-controlled study. J Clin Endocrinol Metab. 2010 Nov; 95(11):4889-97.
    View in: PubMed
    Score: 0.028
  71. Fibroblast growth factor-21 may mediate growth hormone resistance in anorexia nervosa. J Clin Endocrinol Metab. 2010 Jan; 95(1):369-74.
    View in: PubMed
    Score: 0.026
  72. Preadipocyte factor-1 is associated with marrow adiposity and bone mineral density in women with anorexia nervosa. J Clin Endocrinol Metab. 2010 Jan; 95(1):407-13.
    View in: PubMed
    Score: 0.026
  73. Hypercortisolemia is associated with severity of bone loss and depression in hypothalamic amenorrhea and anorexia nervosa. J Clin Endocrinol Metab. 2009 Dec; 94(12):4710-6.
    View in: PubMed
    Score: 0.026
  74. Hormone predictors of abnormal bone microarchitecture in women with anorexia nervosa. Bone. 2010 Feb; 46(2):458-63.
    View in: PubMed
    Score: 0.026
  75. Increased bone marrow fat in anorexia nervosa. J Clin Endocrinol Metab. 2009 Jun; 94(6):2129-36.
    View in: PubMed
    Score: 0.025
  76. Distal radius in adolescent girls with anorexia nervosa: trabecular structure analysis with high-resolution flat-panel volume CT. Radiology. 2008 Dec; 249(3):938-46.
    View in: PubMed
    Score: 0.025
  77. Trabecular structure analysis of the distal radius in adolescent patients with anorexia nervosa using ultra high resolution flat panel based volume CT. J Musculoskelet Neuronal Interact. 2008 Oct-Dec; 8(4):315.
    View in: PubMed
    Score: 0.024
  78. Determinants of height in adolescent girls with anorexia nervosa. Pediatrics. 2008 Jun; 121(6):e1517-23.
    View in: PubMed
    Score: 0.024
  79. Hormonal and nutritional effects on cardiovascular risk markers in young women. J Clin Endocrinol Metab. 2007 Aug; 92(8):3089-94.
    View in: PubMed
    Score: 0.022
  80. Abnormal bone mineral accrual in adolescent girls with anorexia nervosa. J Clin Endocrinol Metab. 2002 Sep; 87(9):4177-85.
    View in: PubMed
    Score: 0.016
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
© 2022 President and Fellows of Harvard College
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.